Terms: = Breast cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1 AND Diagnosis
108 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative breast cancer.
Gardi N; Chaubal R; Parab P; Pachakar S; Kulkarni S; Shet T; Joshi S; Kembhavi Y; Chandrani P; Quist J; Kowtal P; Grigoriadis A; Sarin R; Govindarajan R; Gupta S
Cancer Res Commun; 2024 Feb; 4(2):404-417. PubMed ID: 38315150
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the Clinical Use of Molecular Profiling of Intrahepatic Cholangiocarcinoma in a Comprehensive Multidisciplinary Clinic.
Purchla J; Ghabi EM; Burns WR; Lafaro KJ; Burkhart RA; Cameron JL; Yarchoan M; Shubert CR; Baretti M; He J
J Am Coll Surg; 2024 Apr; 238(4):532-540. PubMed ID: 38189646
[TBL] [Abstract] [Full Text] [Related]
4. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
[TBL] [Abstract] [Full Text] [Related]
5. Omics sciences and precision medicine in thyroid cancer.
Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
[TBL] [Abstract] [Full Text] [Related]
6. Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab.
Axiaris G; Ioannou A; Papoutsaki M; Marinos L; Liontos M; Michopoulos S; Zampeli E
F1000Res; 2022; 11():424. PubMed ID: 37867623
[TBL] [Abstract] [Full Text] [Related]
7. Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review.
Ribeiro LM; Bomtempo FF; Rocha RB; Telles JPM; Neto EB; Figueiredo EG
Clin Exp Metastasis; 2023 Dec; 40(6):445-463. PubMed ID: 37819546
[TBL] [Abstract] [Full Text] [Related]
8. The value of radiomics model based on ultrasound image features in the differentiation between minimal breast cancer and small benign breast masses.
Lyu S; Zhang M; Zhang B; Zhu J; Gao L; Qiu Y; Yang L; Zhang Y
J Clin Ultrasound; 2023; 51(9):1536-1543. PubMed ID: 37712556
[TBL] [Abstract] [Full Text] [Related]
9. breast cancer screening and its associating factors among hungarian women aged 45-65: a cross-sectional study based on the European health interview surveys from 2009 to 2019.
Pataki J; Dombrádi V; Sárváry A; Szőllősi GJ
BMC Public Health; 2023 Aug; 23(1):1679. PubMed ID: 37653363
[TBL] [Abstract] [Full Text] [Related]
10. Integrating US-guided FNAB, braf
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract] [Full Text] [Related]
11. Mutational profiling of Chinese patients with thyroid cancer.
Du Y; Zhang S; Zhang G; Hu J; Zhao L; Xiong Y; Shen L; Chen R; Ye K; Xu Y
Front Endocrinol (Lausanne); 2023; 14():1156999. PubMed ID: 37465126
[TBL] [Abstract] [Full Text] [Related]
12. Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma.
Ma T; Shi P; Ma T; Liang M; Wang L; Shi Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11073-11083. PubMed ID: 37340187
[TBL] [Abstract] [Full Text] [Related]
13. The feasibility of a novel computer-aided classification system for the characterisation and diagnosis of breast masses on ultrasound: a single-centre preliminary test study.
Gu Y; Xu W; Liu Y; An X; Li J; Cong L; Zhu L; He X; Wang H; Jiang Y
Clin Radiol; 2023 Jul; 78(7):e516-e525. PubMed ID: 37069025
[TBL] [Abstract] [Full Text] [Related]
14. Significance of FNAC, braf mutation, and intraoperative frozen section in surgical decision-making of thyroid nodules.
Zhu Z; Su C; Chen G; Wan F; Jin M; Duan X; Wang Y; Wang G
Diagn Cytopathol; 2023 Jul; 51(7):441-448. PubMed ID: 37042168
[TBL] [Abstract] [Full Text] [Related]
15. Novel therapeutics in low-grade serous ovarian cancer.
Cobb L; Gershenson D
Int J Gynecol Cancer; 2023 Mar; 33(3):377-384. PubMed ID: 36878564
[TBL] [Abstract] [Full Text] [Related]
16. Prior Thyroid and Nonthyroid cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid cancer.
Chen YH; Cabanillas M; Sperling J; Xu L; Goswami M; Maniakas A; Williams MD; Lai SY; Busaidy N; Dadu R; Zafereo ME; Wang JR
Thyroid; 2023 Mar; 33(3):321-329. PubMed ID: 36511380
[No Abstract] [Full Text] [Related]
17. braf V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes.
Rothrock AT; Hameed N; Cho WC; Nagarajan P; Ivan D; Torres-Cabala CA; Prieto VG; Curry JL; Aung PP
J Cutan Pathol; 2023 Mar; 50(3):223-229. PubMed ID: 36377266
[TBL] [Abstract] [Full Text] [Related]
18. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China].
Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H
Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767
[No Abstract] [Full Text] [Related]
19. MRI can accurately diagnose breast cancer during lactation.
Nissan N; Massasa EEM; Bauer E; Halshtok-Neiman O; Shalmon A; Gotlieb M; Faermann R; Samoocha D; Yagil Y; Ziv-Baran T; Anaby D; Sklair-Levy M
Eur Radiol; 2023 Apr; 33(4):2935-2944. PubMed ID: 36348090
[TBL] [Abstract] [Full Text] [Related]
20. Stereotactic Body Radiation Therapy for Lung and Liver Oligometastases from breast cancer: Toxicity Data of a Prospective Non-Randomized Phase II Trial.
Franceschini D; Comito T; Di Gallo A; Vernier V; Marzo MA; Di Cristina L; Marini B; Lo Faro L; Stefanini S; Spoto R; Dominici L; Franzese C; Scorsetti M
Curr Oncol; 2022 Oct; 29(10):7858-7867. PubMed ID: 36290898
[TBL] [Abstract] [Full Text] [Related]
[Next]
